Pravin Kamble

675 total citations
34 papers, 499 citations indexed

About

Pravin Kamble is a scholar working on Genetics, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Pravin Kamble has authored 34 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Epidemiology and 10 papers in Psychiatry and Mental health. Recurrent topics in Pravin Kamble's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (6 papers). Pravin Kamble is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (6 papers). Pravin Kamble collaborates with scholars based in United States, Canada and Switzerland. Pravin Kamble's co-authors include Rajender R. Aparasu, Hua Chen, Jeffrey T. Sherer, Joanna Huang, Jonathan Bouchard, Sandipan Bhattacharjee, Swapna Karkare, Jennifer Hayden, Raymond A. Harvey and Swetha Palli and has published in prestigious journals such as The American Journal of Surgery, Psychiatric Services and Journal of Clinical Gastroenterology.

In The Last Decade

Pravin Kamble

31 papers receiving 483 citations

Peers

Pravin Kamble
Tony Foley Ireland
Louisa Gibson Australia
Thang Pham Vietnam
Michael Dörks Germany
Juliette L. Parlevliet Netherlands
Siska Desplenter Belgium
Monica Cepoiu‐Martin Canada
Janine Calver Australia
Weiju Zhou China
Parveen Kumar India
Tony Foley Ireland
Pravin Kamble
Citations per year, relative to Pravin Kamble Pravin Kamble (= 1×) peers Tony Foley

Countries citing papers authored by Pravin Kamble

Since Specialization
Citations

This map shows the geographic impact of Pravin Kamble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pravin Kamble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pravin Kamble more than expected).

Fields of papers citing papers by Pravin Kamble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pravin Kamble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pravin Kamble. The network helps show where Pravin Kamble may publish in the future.

Co-authorship network of co-authors of Pravin Kamble

This figure shows the co-authorship network connecting the top 25 collaborators of Pravin Kamble. A scholar is included among the top collaborators of Pravin Kamble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pravin Kamble. Pravin Kamble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamble, Pravin, et al.. (2025). Clinical use of vedolizumab subcutaneous formulation in inflammatory bowel diseases: a review of real-world evidence. International Journal of Colorectal Disease. 40(1). 179–179.
2.
Scharl, Michael, Britt Christensen, Brian Bressler, et al.. (2025). Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naive Patients With Crohn’s Disease By Disease Location. Journal of Clinical Gastroenterology.
3.
Boeckxstaens, Guy E., Sabry Ayad, George E. Dukes, et al.. (2024). A randomized phase 2 study of the 5-HT4 receptor agonist felcisetrag for postoperative gastrointestinal dysfunction after bowel surgery. The American Journal of Surgery. 234. 162–171. 1 indexed citations
4.
Yarur, Andrés, Gerassimos J. Mantzaris, Song Wang, et al.. (2024). Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study. Advances in Therapy. 41(6). 2324–2341. 2 indexed citations
5.
Christensen, Britt, et al.. (2023). P636 Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naïve patients with Crohn’s disease: Results from the EVOLVE Expansion study. Journal of Crohn s and Colitis. 17(Supplement_1). i768–i769. 2 indexed citations
6.
Mantzaris, Gerassimos J., Brian Bressler, Shashi Adsul, et al.. (2023). Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn’s disease: results from the EVOLVE study. European Journal of Gastroenterology & Hepatology. 36(3). 281–291. 4 indexed citations
7.
Danese, Silvio, Pravin Kamble, Jin Yang, et al.. (2022). Systematic Literature Review and Meta-analysis: Real-World Mucosal Healing in Vedolizumab-Treated Patients with Crohn’s Disease. INFM-OAR (INFN Catania). 2022. 1–12. 2 indexed citations
8.
Kamble, Pravin, et al.. (2019). Object Detection using Convolutional Neural Network in the Application of Supplementary Nutrition Value of Fruits. International Journal of Innovative Technology and Exploring Engineering. 8(11). 725–729. 6 indexed citations
9.
Kamble, Pravin, Jennifer Hayden, Jenna Collins, et al.. (2018). Association of obesity with healthcare resource utilization and costs in a commercial population. Current Medical Research and Opinion. 34(7). 1335–1343. 18 indexed citations
10.
Kamble, Pravin, et al.. (2018). Understanding Prediabetes in a Medicare Advantage Population Using Data Adaptive Techniques. Population Health Management. 21(6). 477–485. 1 indexed citations
11.
Kamble, Pravin, Raymond A. Harvey, B. Gabriel Smolarz, et al.. (2017). Positive predictive value between medical-chart body-mass-index category and obesity versus codes in a claims-data warehouse. Current Medical Research and Opinion. 34(1). 117–121. 3 indexed citations
12.
Harvey, Raymond A., Jennifer Hayden, Pravin Kamble, Jonathan Bouchard, & Joanna Huang. (2016). A comparison of entropy balance and probability weighting methods to generalize observational cohorts to a population: a simulation and empirical example. Pharmacoepidemiology and Drug Safety. 26(4). 368–377. 39 indexed citations
13.
14.
Kamble, Pravin, Hua Chen, Michael L. Johnson, Vinod S. Bhatara, & Rajender R. Aparasu. (2014). Concurrent Use of Stimulants and Second-Generation Antipsychotics Among Children With ADHD Enrolled in Medicaid. Psychiatric Services. 66(4). 404–410. 24 indexed citations
15.
Palli, Swetha, Pravin Kamble, Hua Chen, & Rajender R. Aparasu. (2012). Persistence of Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 22(2). 139–148. 30 indexed citations
16.
Bhattacharjee, Sandipan, Swapna Karkare, Pravin Kamble, & Rajender R. Aparasu. (2010). Datapoints: Psychotropic Drug Utilization Among Elderly Nursing Home Residents in the United States. Psychiatric Services. 61(7). 655–655. 6 indexed citations
17.
Kamble, Pravin, et al.. (2010). Off-Label Use of Second-Generation Antipsychotic Agents Among Elderly Nursing Home Residents. Psychiatric Services. 61(2). 130–136. 53 indexed citations
18.
Bhattacharjee, Sandipan, Swapna Karkare, Pravin Kamble, & Rajender R. Aparasu. (2010). Datapoints: Psychotropic Drug Utilization Among Elderly Nursing Home Residents in the United States. Psychiatric Services. 61(7). 4 indexed citations
19.
Kamble, Pravin, Hua Chen, Jeffrey T. Sherer, & Rajender R. Aparasu. (2009). Use of Antipsychotics among Elderly Nursing Home Residents with Dementia in the US. Drugs & Aging. 26(6). 483–492. 84 indexed citations
20.
Kamble, Pravin, et al.. (2008). Antipsychotic drug use among elderly nursing home residents in the United States. ˜The œAmerican journal of geriatric pharmacotherapy. 6(4). 187–197. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tony Foley Breakdown of academic impact, for papers by Louisa Gibson Breakdown of academic impact, for papers by Thang Pham Breakdown of academic impact, for papers by Michael Dörks Breakdown of academic impact, for papers by Juliette L. Parlevliet Breakdown of academic impact, for papers by Siska Desplenter Breakdown of academic impact, for papers by Monica Cepoiu‐Martin Breakdown of academic impact, for papers by Janine Calver Breakdown of academic impact, for papers by Weiju Zhou Breakdown of academic impact, for papers by Parveen Kumar
Rankless by CCL
2026